Medicenna Therapeutics Corp.

MDNA.TO·Toronto·Healthcare
Compare
0.4500+0.0100 (+2.27%)today
At close: Oct 16, 3:15 PM EDT · May be delayed up to 15 min · CAD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close0.4400
Open0.4400
Day range0.44000.4500
52-week range0.33501.9700
Off day high0.00%
Off 52-week high−77.16%
Volume20.03K
Avg. volume (3M)44.60K
Market cap41.54M
EPS (TTM)-0.2200
Forward P/E-1.96
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)2.10
Shares outstanding92.30M
Short interest0.32% of float
Earnings dateNov 12, 2026 (est.)
Analyst target3.2000
Profit margin0.00%

Against its peers

Compare in full ›
MDNA.TO CHRS HOWL BCTX HURA INMB
Market cap 41.54M 152.96M 47.63M 29.58M 112.16M 43.57M
P/E (TTM) — — — — — —
Forward P/E -2.0 -1.6 -1.7 -8.7 -2.9 -3.7
Price/book 25.0 2.5 2.9 1.0 6.2 2.1
Dividend yield — — — — — —
1-year change −51.11% −44.69% −37.69% −68.19% −28.16% −10.81%
Today +2.27% −7.48% −1.71% −9.69% −3.83% −4.85%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to MDNA.TO's by what they do, from their descriptions, with the same industry weighted in.

Company Mkt cap Price Today
Coherus Oncology, Inc.CHRS · Biotechnology 152.96M 0.9900 −7.48%
Werewolf Therapeutics, Inc.HOWL · Biotechnology 47.63M 0.9800 −1.71%
BriaCell Therapeutics Corp.BCTX · Biotechnology 29.58M 3.4000 −9.69%
TuHURA Biosciences, Inc.HURA · Biotechnology 112.16M 1.7600 −3.83%
INmune Bio Inc.INMB · Biotechnology 43.57M 1.5700 −4.85%
MediciNova, Inc.MNOV · Biotechnology 69.89M 1.4200 −2.07%
Apollomics, Inc.APLM · Biotechnology 61.51M 21.10 −0.00%
PDS Biotechnology CorporationPDSB · Biotechnology 81.90M 1.1300 −13.08%

From the 4Conservative instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 15 min.

Latest news

All MDNA.TO news ›
Stock Titan·

MediciNova CEO Provides Shareholder Update

3iQ Receives In-Principal Approval from Abu Dhabi's IFC MediciNova (MNOV) updated shareholders on its MN-001 Phase 2 trial, which did not achieve statistical significance on its primary endpoints. The double-blind portion of COMBAT-ALS,…

Stock Titan·

Medline to report third quarter 2026 results on November 4, 2026

Netlist and Micron Enter Patent License and Settlement Agreements Medline (MDLN) plans to report its third quarter 2026 financial results before the market opens on November 4, 2026. A webcast and conference call to discuss the results…

From articles in the 4Search news index.

In the news

3mentions in 30 days
1with it in the headline
Positivesentiment

Mentioned with

Medicenna3Medicenna Therapeutics Corp.3Mnp Llp3Abcellera Biologics Inc1Arcturus Therapeutics Holdings Inc1Artisan Partners1Ascentage Pharma1Avidity1

People in the coverage

Medicenna3Adam Jourdan1Alexander1Alissa Maupin1Annie J. Cheng1Artisan1

Themes

Results3Therapeutics3Financial2Provides2Quarter2Reports2Second2Update2

Most coverage from

  1. stocktitan.net2
  2. kalkinemedia.com1

Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.